ProofPilot’s 2025: What We Built, Who We Partnered With, and What’s Ahead
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
GxP compliance is becoming increasingly critical for a patient recruitment capability, and for good...
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
ProofPilot’s acquisition of Lokavant is a move that will have a significant, high-value impact on...
In clinical research, adopting new technology to solve important challenges is often a colossal...
The success of a clinical trial is often measured with metrics and milestones. But patient advocate...
According to SCRS, complexity was one of the top three reasons why a site will decline a study. In...
It’s a familiar story in clinical research: a referral comes through, the patient looks like a...
Clinical trial recruitment has long been treated as a numbers game. Get as many eligible patients...